Close Menu

NEW YORK – Rutherford, New Jersey-based Cancer Genetics said on Monday that it will acquire all outstanding capital stock of organoid startup Stemonix in exchange for a number of shares of its common stock.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.